1. Home
  2. ASIC vs XNCR Comparison

ASIC vs XNCR Comparison

Compare ASIC & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ASIC

Ategrity Specialty Insurance Company Holdings

HOLD

Current Price

$20.81

Market Cap

930.6M

Sector

Finance

ML Signal

HOLD

Logo Xencor Inc.

XNCR

Xencor Inc.

HOLD

Current Price

$11.26

Market Cap

881.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASIC
XNCR
Founded
2018
1997
Country
United States
United States
Employees
203
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
930.6M
881.9M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
ASIC
XNCR
Price
$20.81
$11.26
Analyst Decision
Buy
Buy
Analyst Count
4
9
Target Price
$26.75
$22.33
AVG Volume (30 Days)
61.8K
712.4K
Earning Date
04-29-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
65.36
EPS
N/A
N/A
Revenue
N/A
$125,576,000.00
Revenue This Year
$34.21
N/A
Revenue Next Year
$34.65
$4.80
P/E Ratio
$98.60
N/A
Revenue Growth
N/A
13.65
52 Week Low
$16.35
$6.92
52 Week High
$23.88
$18.69

Technical Indicators

Market Signals
Indicator
ASIC
XNCR
Relative Strength Index (RSI) 57.07 42.24
Support Level $20.32 $11.02
Resistance Level $20.87 $13.28
Average True Range (ATR) 0.63 0.72
MACD 0.16 -0.16
Stochastic Oscillator 73.99 24.53

Price Performance

Historical Comparison
ASIC
XNCR

About ASIC Ategrity Specialty Insurance Company Holdings

Ategrity Specialty Insurance Co Holdings is a specialty property and casualty insurance holding company focused on the excess and surplus market for small to medium-sized businesses (SMBs) across the United States. Operating through its subsidiaries, the company underwrites small and medium-sized commercial risks across selected industry verticals, including Retail, Real Estate, Hospitality, and Construction. Its operating model uses a technology-driven method to standardize, simplify, and, where appropriate, automate these transactions. The group distributes its products through licensed surplus lines brokers and wholesale agents.

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

Share on Social Networks: